tiprankstipranks
Trending News
More News >
Y-Mabs Therapeutics (YMAB)
NASDAQ:YMAB
US Market

Y-Mabs Therapeutics (YMAB) Ownership - Who Owns Y-Mabs Therapeutics?

Compare
516 Followers

Y-Mabs Therapeutics (YMAB) Ownership Overview

17.07%7.81%36.10%9.08%29.94%
17.07% Insiders
36.10% Other Institutional Investors
9.08% ETFs
29.94% Public Companies and Individual Investors
The ownership structure of Y-Mabs Therapeutics (YMAB) stock is a mix of institutional, retail, and individual investors. Approximately 52.99% of the company’s stock is owned by Institutional Investors, 17.07% is owned by Insiders, and 29.94% is owned by Public Companies and Individual Investors.
The ownership structure of Y-Mabs Therapeutics (YMAB) stock is a mix of institutional, retail, and individual investors. Approximately 43.91% of the company’s stock is owned by Institutional Investors, 17.07% is owned by Insiders, and 9.08% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 11, 2025
xxxxxxxxxxxxx
$56536
Mar 11, 2025
xxxxxxxxxxxxx
$20368
Sep 17, 2024
xxxxxxxxxxxxx
$1264650
Aug 30, 2024
xxxxxxxxxxxxx
$768500

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$56057

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,565,058Insider10.08%17,621,124
2,225,881Insider4.92%8,591,901
1,851,788Institution4.09%7,147,902
1,676,589Institution3.70%6,471,634
1,540,964Institution3.40%5,948,121
396,749Institution0.88%1,531,451
338,227Institution0.75%1,305,556
330,402Insider0.73%1,275,352
220,831Institution0.49%852,408
210,877Insider0.47%813,985

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,540,964Institution3.40%5,948,121
396,749Institution0.88%1,531,451
338,227Institution0.75%1,305,556
220,831Institution0.49%852,408
209,064Institution0.46%806,987
188,163Institution0.42%726,309
104,853Institution0.23%404,733
98,087Institution0.22%378,616
55,000Institution0.12%212,300
49,900Institution0.11%192,614

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,040,061Institution2.30%4,420,259
937,874Institution2.07%3,620,194
500,903Institution1.11%2,128,838
321,677Institution0.71%1,241,673
213,760Institution0.47%825,114
185,832Institution0.41%789,786
156,983Institution0.35%571,418
96,625Institution0.21%410,656
76,083Institution0.17%293,680
69,367Institution0.15%252,496

FAQ

Who Owns Y-Mabs Therapeutics (YMAB)?
According to the latest TipRanks data, approximately 36.10% of the company's stock is held by institutional investors, 17.07% is held by insiders, and 29.94% is held by retail investors.
    What percentage of Y-Mabs Therapeutics (YMAB) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 36.10% of Y-Mabs Therapeutics (YMAB) stock is held by institutional investors.
      What percentage of Y-Mabs Therapeutics (YMAB) stock is held by retail investors?
      According to the latest TipRanks data, approximately 29.94% of Y-Mabs Therapeutics (YMAB) stock is held by retail investors.
        Who owns the most shares of Y-Mabs Therapeutics (YMAB)?
        Johan Wedell-Wedellsborg owns the most shares of Y-Mabs Therapeutics (YMAB).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis